Praxis Precision Medicines (PRAX) Shares Outstanding (2019 - 2026)
Praxis Precision Medicines (PRAX) posted quarterly Shares Outstanding (Entity) of $27.9 million for Q1 2026, up 36.96% year-over-year from $20.3 million in Q1 2025, and up 10.58% quarter-over-quarter from $25.2 million in Q4 2025.
Praxis Precision Medicines (PRAX) Shares Outstanding (2019 - 2026) Analysis & Trends
Praxis Precision Medicines' Shares Outstanding (Entity) history runs 8 years deep, the most recent figure standing at $27.9 million for Q1 2026.
- In Q1 2026, Shares Outstanding (Entity) rose 36.96% year-over-year to $27.9 million; the TTM figure through Mar 2026 stood at $27.9 million (up 36.96% YoY), while the FY2025 annual figure was $25.2 million, up 29.72% from the prior year.
- Shares Outstanding (Entity) for Q1 2026 stood at $27.9 million, up from $25.2 million in the prior quarter.
- The five-year high for Shares Outstanding (Entity) was $27.9 million in Q1 2026, with the low at $3.0 million in Q1 2022.
- The 5-year median for Shares Outstanding (Entity) is $13.3 million (2024), against an average of $12.9 million.
- The sharpest annual moves came in 2022 and 2024: Shares Outstanding (Entity) gained 1.97% in 2022, then jumped 281.87% in 2024.
- Praxis Precision Medicines' Shares Outstanding (Entity) stood at $3.3 million in 2022, then soared by 100.29% to $6.6 million in 2023, then soared by 194.53% to $19.4 million in 2024, then gained by 29.72% to $25.2 million in 2025, then climbed by 10.58% to $27.9 million in 2026.
- Business Quant data shows PRAX's Shares Outstanding (Entity) at $27.9 million in Q1 2026, $25.2 million in Q4 2025, and $21.2 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Shares Outstanding (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn | 253.70 Mn |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn | 102.80 Mn |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn | 62.19 Mn |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - | 210.89 Mn |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn | 1.45 Bn |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn | 25.05 Bn |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - | 445.06 Mn |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn | 133.61 Mn |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn | 217.35 Mn |
| 10 | Praxis Precision Medicines | 10.24 Bn | 9.48 Bn | - | 29.13 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 29.13 Mn |
| Mar 31, 2026 | 28.88 Mn |
| Dec 31, 2025 | 22.50 Mn |
| Sep 30, 2025 | 21.98 Mn |
| Jun 30, 2025 | 21.47 Mn |
| Mar 31, 2025 | 21.06 Mn |
| Dec 31, 2024 | 17.91 Mn |
| Sep 30, 2024 | 18.88 Mn |
| Jun 30, 2024 | 18.82 Mn |
| Mar 31, 2024 | 13.90 Mn |
| Dec 31, 2023 | 6.59 Mn |
| Sep 30, 2023 | 9.04 Mn |
| Jun 30, 2023 | 4.65 Mn |
| Mar 31, 2023 | 3.54 Mn |
| Dec 31, 2022 | 3.07 Mn |
| Sep 30, 2022 | 3.05 Mn |
| Jun 30, 2022 | 3.04 Mn |
| Mar 31, 2022 | 3.03 Mn |
| Dec 31, 2021 | 2.83 Mn |
| Sep 30, 2021 | 2.98 Mn |